{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T13:54:58Z","timestamp":1791294898589,"version":"4.1.0"},"reference-count":83,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2009,4,1]],"date-time":"2009-04-01T00:00:00Z","timestamp":1238544000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,4,1]],"date-time":"2009-04-01T00:00:00Z","timestamp":1238544000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain Research Bulletin"],"published-print":{"date-parts":[[2009,4]]},"DOI":"10.1016\/j.brainresbull.2009.01.005","type":"journal-article","created":{"date-parts":[[2009,1,31]],"date-time":"2009-01-31T04:38:29Z","timestamp":1233376709000},"page":"130-141","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":82,"title":["The consolidation of neuroleptic therapy: Janssen, the discovery of haloperidol and its introduction into clinical practice"],"prefix":"10.1016","volume":"79","author":[{"given":"Francisco","family":"L\u00f3pez-Mu\u00f1oz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilio","family":"Alamo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl. 1","key":"10.1016\/j.brainresbull.2009.01.005_bib1","first-page":"13","article-title":"Historia de los f\u00e1rmacos analg\u00e9sicos (I): Agentes opioides","volume":"13","author":"Alamo","year":"2006","journal-title":"Rev. Soc. Esp. Dolor"},{"key":"10.1016\/j.brainresbull.2009.01.005_bib2","series-title":"Nuevos Antipsic\u00f3ticos At\u00edpicos","first-page":"1","article-title":"Antipsic\u00f3ticos at\u00edpicos: perfil receptorial","author":"Alamo","year":"1996"},{"key":"10.1016\/j.brainresbull.2009.01.005_bib3","first-page":"130","article-title":"La contribuci\u00f3n de la reserpina al desarrollo de la psiquiatr\u00eda y su papel en la investigaci\u00f3n neurobiol\u00f3gica","volume":"31","author":"Alamo","year":"2004","journal-title":"Rev. Psiquiatr. Fac. Med. Barc."},{"key":"10.1016\/j.brainresbull.2009.01.005_bib4","series-title":"Neuroleptic Tranquillizer and Antidepression","author":"Arnold","year":"1962"},{"key":"10.1016\/j.brainresbull.2009.01.005_bib5","series-title":"Reflections on Twentieth-Century Psychopharmacology","first-page":"35","article-title":"The history of psychotropic drugs at Janssen Research","author":"Awouters","year":"2004"},{"key":"10.1016\/j.brainresbull.2009.01.005_bib6","first-page":"625","article-title":"Forty years of antipsychotic drug research \u2013 from haloperidol to paliperidona \u2013 with Dr. Paul Janssen","volume":"57","author":"Awouters","year":"2007","journal-title":"Arzneim. Forsch. Drug Res."},{"key":"10.1016\/j.brainresbull.2009.01.005_bib7","first-page":"71","article-title":"The early history of modern psychopharmacology","volume":"5","author":"Ayd","year":"1991","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.brainresbull.2009.01.005_bib8","series-title":"De haloperiol a risperidona. 35 a\u00f1os de investigaci\u00f3n en psiquiatr\u00eda","article-title":"Treinta y cinco a\u00f1os de experiencia cl\u00ednica con haloperidol","author":"Ayd","year":"1994"},{"key":"10.1016\/j.brainresbull.2009.01.005_bib9","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0278-5846(01)00160-9","article-title":"Pharmacotherapy of mental illness. A historical analysis","volume":"25","author":"Ban","year":"2001","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatr."},{"key":"10.1016\/j.brainresbull.2009.01.005_bib10","series-title":"Reflections on Twentieth-Century Psychopharmacology","article-title":"Paul Adriaan Jan Janssen. Pioneer and President (1980\u20131982)","author":"Ban","year":"2004"},{"key":"10.1016\/j.brainresbull.2009.01.005_bib11","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1111\/j.2042-7158.1956.tb12217.x","article-title":"Analgesic and their antagonists: some steric and chemical considerations. Part III: the influence of the basic group on the biological response","volume":"8","author":"Beckett","year":"1956","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.brainresbull.2009.01.005_bib12","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1021\/jm040195b","article-title":"A personal perspective on Dr. Paul Janssen","volume":"48","author":"Black","year":"2005","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.brainresbull.2009.01.005_bib13","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/0010-440X(72)90017-X","article-title":"Clinical classification of neuroleptics, with special references to their antimanic, antiaustistic and ataraxic properties","volume":"13","author":"Bobon","year":"1972","journal-title":"Compr. Psychiatr."},{"key":"10.1016\/j.brainresbull.2009.01.005_bib14","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1126\/science.122.3177.968.a","article-title":"Evidence that serotonin has a role in brain function","volume":"222","author":"Brodie","year":"1955","journal-title":"Science"},{"key":"10.1016\/j.brainresbull.2009.01.005_bib15","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1176\/ajp.135.2.164","article-title":"Antipsychotic drugs, neurotransmitters, and schizophrenia","volume":"135","author":"Carlsson","year":"1978","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.brainresbull.2009.01.005_bib16","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/j.1600-0773.1963.tb01730.x","article-title":"Effect of chlorpromazine or haloperidol on formation of 3-methoxytyramine and normetanephrine in mouse brain","volume":"20","author":"Carlsson","year":"1963","journal-title":"Acta Pharmacol. Toxicol."},{"key":"10.1016\/j.brainresbull.2009.01.005_bib17","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1038\/1801200a0","article-title":"3,4-dihydroxy phenylalanine and 5-hydroxy tryptophan as reserpine antagonists","volume":"180","author":"Carlsson","year":"1957","journal-title":"Nature"},{"key":"10.1016\/j.brainresbull.2009.01.005_bib18","series-title":"Fundamentos biol\u00f3gicos en psiquiatr\u00eda","first-page":"3","article-title":"Psiquiatr\u00eda Biol\u00f3gica: Historia y m\u00e9todo","author":"Colodr\u00f3n","year":"1999"},{"key":"10.1016\/j.brainresbull.2009.01.005_bib19","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/S0003-4509(04)94313-1","article-title":"Paul F. Janssen (1926\u20132003). Deux d\u00e9couvertes par an","volume":"62","author":"Chast","year":"2004","journal-title":"Ann. Pharm. Fr."},{"key":"10.1016\/j.brainresbull.2009.01.005_bib20","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S0022-3565(25)11898-3","article-title":"Modification of the pharmacology of reserpine and serotonin by iproniazid","volume":"119","author":"Chessin","year":"1957","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.brainresbull.2009.01.005_bib21","first-page":"331","article-title":"Pharmacological properties of a series of basic phenylacetamides","volume":"3","author":"De Jongh","year":"1954","journal-title":"Acta Physiol. Pharmacol. Neerl."},{"key":"10.1016\/j.brainresbull.2009.01.005_bib22","series-title":"Psychotropic Drugs","first-page":"485","article-title":"Caract\u00e9ristiques psycho-physiologiques des m\u00e9dicaments neurol\u00e9ptiques","author":"Delay","year":"1957"},{"key":"10.1016\/j.brainresbull.2009.01.005_bib23","series-title":"M\u00e9thodes Chimioth\u00e9rapeutiques en Psychiatrie","author":"Delay","year":"1961"},{"key":"10.1016\/j.brainresbull.2009.01.005_bib24","first-page":"21","article-title":"L\u2019action de \u013ahalop\u00e9ridol dans les psychoses","volume":"60","author":"Delay","year":"1960","journal-title":"Acta Neurol. Psychiatr. Belg."},{"key":"10.1016\/j.brainresbull.2009.01.005_bib25","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1176\/ajp.116.4.356","article-title":"Problems in evaluation of R 1625","volume":"116","author":"Denber","year":"1959","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.brainresbull.2009.01.005_bib26","series-title":"Entretiens de Bichat","author":"Deniker","year":"1977"},{"key":"10.1016\/j.brainresbull.2009.01.005_bib27","first-page":"878","article-title":"Le R 1625: Nouvelle th\u00e9rapeutique symptomatique de l\u2019agitation psychomotrice","volume":"58","author":"Divry","year":"1958","journal-title":"Acta Neurol. Psychiatr. Belg."},{"key":"10.1016\/j.brainresbull.2009.01.005_bib28","first-page":"337","article-title":"\u00c9tude et exp\u00e9rimentations cliniques du R 1625 ou halop\u00e9ridol, nouveau neuroleptique et \u201cneurodysleptique\u201d","volume":"59","author":"Divry","year":"1959","journal-title":"Acta Neurol. Psychiatr. Belg."},{"key":"10.1016\/j.brainresbull.2009.01.005_bib29","volume":"60","author":"Divry","year":"1960","journal-title":"Acta Med. Belg."},{"key":"10.1016\/j.brainresbull.2009.01.005_bib30","first-page":"7","article-title":"Rapport sur l\u2019activit\u00e9 neuro-psychopharmacologique du haloperidol (R 1625)","volume":"60","author":"Divry","year":"1960","journal-title":"Acta Neurol. Psychiatr. Belg."},{"key":"10.1016\/j.brainresbull.2009.01.005_bib31","first-page":"536","article-title":"A new morphine-like analgesic","volume":"8","author":"Eddy","year":"1947","journal-title":"J. Am. Pharm. Assoc."},{"key":"10.1016\/j.brainresbull.2009.01.005_bib32","series-title":"Actualit\u00e9s de Th\u00e9rapeutique Psychiatrique","first-page":"159","article-title":"Pipamperone","author":"Fouks","year":"1972"},{"key":"10.1016\/j.brainresbull.2009.01.005_bib33","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S0193-953X(18)30098-4","article-title":"History of the development of antipsychotic medication","volume":"17","author":"Frankenburg","year":"1994","journal-title":"Psychiatr. Clin. North Am."},{"key":"10.1016\/j.brainresbull.2009.01.005_bib34","first-page":"149","article-title":"Les neuroleptiques. D\u00e9veloppement et situation actuelle","volume":"XVII","author":"Ginestet","year":"1991","journal-title":"L\u2019Encephale"},{"key":"10.1016\/j.brainresbull.2009.01.005_bib35","first-page":"59","article-title":"La d\u00e9couverte de l\u2019halop\u00e9ridol","volume":"25","author":"Granger","year":"1999","journal-title":"L\u2019Enc\u00e9phale"},{"key":"10.1016\/j.brainresbull.2009.01.005_bib36","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1080\/10401230591002048","article-title":"The haloperidol story","volume":"17","author":"Granger","year":"2005","journal-title":"Ann. Clin. Psychiatry"},{"key":"10.1016\/j.brainresbull.2009.01.005_bib37","series-title":"Historia de la Psicofarmacolog\u00eda","article-title":"Antipsic\u00f3ticos (III). La consolidaci\u00f3n de la terap\u00e9utica neurol\u00e9ptica: la introducci\u00f3n cl\u00ednica del haloperidol y el desarrollo de las butirofenonas y tioxantenos","author":"Granger","year":"2007"},{"key":"10.1016\/j.brainresbull.2009.01.005_bib38","series-title":"A Psychiatric, Neurological and Pharmacological Investigation","article-title":"The actions of neuroleptic drugs","author":"Haase","year":"1985"},{"key":"10.1016\/j.brainresbull.2009.01.005_bib39","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1471-4159.1956.tb12048.x","article-title":"Depression by reserpine of the noradrenergic concentration in the hypothalamus of the cat","volume":"1","author":"Holzbauer","year":"1956","journal-title":"J. Neurochem."},{"key":"10.1016\/j.brainresbull.2009.01.005_bib40","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1007\/BF00310617","article-title":"The early history of psychotherapeutic drugs","volume":"89","author":"Jacobsen","year":"1986","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.brainresbull.2009.01.005_bib41","doi-asserted-by":"crossref","first-page":"3862","DOI":"10.1021\/ja01596a087","article-title":"A new series of potent analgesics","volume":"78","author":"Janssen","year":"1956","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.brainresbull.2009.01.005_bib42","series-title":"Neuropsychopharmacology: Third Congress. Proceedings of Third CINP Congress","first-page":"331","article-title":"Recent advances in the butyrophenone series","author":"Janssen","year":"1964"},{"key":"10.1016\/j.brainresbull.2009.01.005_bib43","first-page":"1","article-title":"The chemical anatomy of neuroleptic drugs","volume":"65","author":"Janssen","year":"1966","journal-title":"S\u00e4rtryck Farmaceutisk Revy"},{"key":"10.1016\/j.brainresbull.2009.01.005_bib44","series-title":"Discoveries in Biological Psychiatry","first-page":"165","article-title":"The butyrophenone story","author":"Janssen","year":"1984"},{"key":"10.1016\/j.brainresbull.2009.01.005_bib45","series-title":"Janssen Research in Psychiatry","first-page":"9","article-title":"The butyrophenone story","author":"Janssen","year":"1989"},{"key":"10.1016\/j.brainresbull.2009.01.005_bib46","series-title":"A History of the CINP","first-page":"440","article-title":"Haloperidol and the butyrophenones: the early years","author":"Janssen","year":"1996"},{"key":"10.1016\/j.brainresbull.2009.01.005_bib47","series-title":"The Rise of Psychopharmacology and the Story of CINP","first-page":"63","article-title":"Function and dysfunction of the basal ganglia","author":"Janssen","year":"1998"},{"key":"10.1016\/j.brainresbull.2009.01.005_bib48","series-title":"The Psychopharmacologists II","first-page":"39","article-title":"From haloperidol to risperidone","author":"Janssen","year":"1999"},{"key":"10.1016\/j.brainresbull.2009.01.005_bib49","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1021\/jm50005a002","article-title":"Compounds related to pethidine-I. Mannich based derived from various esters of 4-carboxy-4-phenylpiperidine and acetophenones","volume":"1","author":"Janssen","year":"1959","journal-title":"J. Med. Pharm. Chem."},{"key":"10.1016\/j.brainresbull.2009.01.005_bib50","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1021\/jm50002a008","article-title":"Compounds related to pethidine-I. Mannich based derived from norpethidine and acetophenones","volume":"1","author":"Janssen","year":"1959","journal-title":"J. Med. Pharm. Chem."},{"key":"10.1016\/j.brainresbull.2009.01.005_bib51","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/BF00441186","article-title":"Chemistry and pharmacology of compounds related to 4-(4-hydroxy-4-phenyl-piperidino)-butyrophenone. Part IV. Influence of haloperidol (R 1625) and of chlorpromazine on the behaviour of rats in an unfamiliar \u201copen field\u201d situation","volume":"1","author":"Janssen","year":"1960","journal-title":"Psychopharmacologia"},{"key":"10.1016\/j.brainresbull.2009.01.005_bib52","first-page":"373","article-title":"The pharmacology of a new potent analgesic, R951 2-(N-(4-carbethoxy-4-phenyl)-piperidino)-propiophenone HCl","volume":"7","author":"Janssen","year":"1958","journal-title":"Acta Physiol. Pharmacol. Neerl."},{"key":"10.1016\/j.brainresbull.2009.01.005_bib53","first-page":"765","article-title":"Chemistry and pharmacology of compounds related to 4-(4-hydroxy-4-phenyl-piperidino)-butyrophenone. Part II. Inhibition of apomorphine vomiting in dogs","volume":"9","author":"Janssen","year":"1959","journal-title":"Arzneim. Forsch."},{"key":"10.1016\/j.brainresbull.2009.01.005_bib54","first-page":"955","article-title":"Chemistry and pharmacology of compounds related to 4-(4-hydroxy-4-phenyl-piperidino)-butyrophenone. Part III. Duration of antiemetic action and oral effectiveness of haloperidol (R 1625) and of chlorpromazine in dogs","volume":"10","author":"Janssen","year":"1960","journal-title":"Arzneim. Forsch."},{"key":"10.1016\/j.brainresbull.2009.01.005_bib55","first-page":"104","article-title":"Is it possible to predict the clinical effects of neuroleptic drugs (major tranquillizers) from animal data? Part I. \u201cNeuroleptic activity spectra\u201d for rats","volume":"15","author":"Janssen","year":"1965","journal-title":"Arzneim. Forsch."},{"key":"10.1016\/j.brainresbull.2009.01.005_bib56","first-page":"1196","article-title":"Is it possible to predict the clinical effects of neuroleptic drugs (major tranquillizers) from animal data? Part II. \u201cNeuroleptic spectra activity\u201d for dogs","volume":"15","author":"Janssen","year":"1965","journal-title":"Arzneim. Forsch."},{"key":"10.1016\/j.brainresbull.2009.01.005_bib57","first-page":"339","article-title":"Is it possible to predict the clinical effects of neuroleptic drugs (major tranquillizers) from animal data? Part III. The subcutaneous and oral activity in rats and dogs for 56 neuroleptic drugs in the jumping box test","volume":"16","author":"Janssen","year":"1966","journal-title":"Arzneim. Forsch."},{"key":"10.1016\/j.brainresbull.2009.01.005_bib58","first-page":"841","volume":"17","author":"Janssen","year":"1967","journal-title":"Arzneim. Forsch."},{"key":"10.1016\/j.brainresbull.2009.01.005_bib59","first-page":"205","article-title":"The pharmacology of dehydrobenzperidol, a new potent and short acting neuroleptic agent chemically related to haloperidol","volume":"13","author":"Janssen","year":"1963","journal-title":"Arzneim. Forsch."},{"key":"10.1016\/j.brainresbull.2009.01.005_bib60","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1021\/jm50004a007","article-title":"Chemistry and pharmacology of compounds related to 4-(4-hydroxy-4-phenyl-piperidino)-butyrophenone. Part I. Synthesis and screening data in mice","volume":"1","author":"Janssen","year":"1959","journal-title":"J. Med. Pharm. Chem."},{"key":"10.1016\/j.brainresbull.2009.01.005_bib61","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.neuint.2008.04.010","article-title":"Despite irreversible binding, PET tracer [11C]-SA5845 is suitable for imaging of drug competition at sigma receptors-the cases of ketamine and haloperidol","volume":"53","author":"Kortekaas","year":"2008","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.brainresbull.2009.01.005_bib62","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0925-4927(98)00054-7","article-title":"Positive correlation between reduction of handwritting area and D2 dopamine receptor occupancy during treatment with neuroleptic drugs","volume":"90","author":"Kuenstler","year":"1999","journal-title":"Psychiatr. Res. Neuroimag."},{"key":"10.1016\/j.brainresbull.2009.01.005_bib63","first-page":"1509","article-title":"Classification psychopharmacologique et clinique des neuroleptiques","volume":"60","author":"Lambert","year":"1960","journal-title":"Press. M\u00e9d."},{"key":"10.1016\/j.brainresbull.2009.01.005_bib64","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1177\/070674379704200205","article-title":"The history of the psychopharmacology of schizophrenia","volume":"42","author":"Lehmann","year":"1997","journal-title":"Can. J. Psychiatry"},{"key":"10.1016\/j.brainresbull.2009.01.005_bib65","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/S1359-6446(04)03077-6","article-title":"Obituary of Dr. Paul Janssen (1926\u20132003)","volume":"9","author":"Lewi","year":"2004","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.brainresbull.2009.01.005_bib66","first-page":"337","article-title":"A serotonergic component of neuroleptic receptors","volume":"230","author":"Leysen","year":"1977","journal-title":"Arch. Int. Pharmacodyn. Ther."},{"key":"10.1016\/j.brainresbull.2009.01.005_bib67","series-title":"Historia de la Neuropsicofarmacolog\u00eda. Una nueva aportaci\u00f3n a la terap\u00e9utica farmacol\u00f3gica de los trastornos del Sistema Nervioso Central","article-title":"F\u00e1rmacos antipsic\u00f3ticos","author":"L\u00f3pez-Mu\u00f1oz","year":"1998"},{"key":"10.1016\/j.brainresbull.2009.01.005_bib68","unstructured":"F. L\u00f3pez-Mu\u00f1oz, C. Alamo, E. Cuenca, La \u201cD\u00e9cada de Oro\u201d de la Psicofarmacolog\u00eda (1950\u20131960): Trascendencia hist\u00f3rica de la introducci\u00f3n cl\u00ednica de los psicof\u00e1rmacos cl\u00e1sicos, Psiquiatria.COM (electronic journal) 4 (3), September (2000), available at URL http:\/\/www.psiquiatria.com\/psiquiatria\/revista\/47\/1800\/?++interactivo."},{"issue":"3","key":"10.1016\/j.brainresbull.2009.01.005_bib69","first-page":"17","article-title":"La consolidaci\u00f3n de la terap\u00e9utica neurol\u00e9ptica: Janssen y la introducci\u00f3n cl\u00ednica del haloperidol","volume":"II","author":"L\u00f3pez-Mu\u00f1oz","year":"2000","journal-title":"JANO (Psiquiatr\u00eda y Humanidades)"},{"key":"10.1016\/j.brainresbull.2009.01.005_bib70","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0278-5846(03)00165-9","article-title":"Half a century since the clinical introduction of chlorpromazine and the birth of modern psychopharmacology","volume":"28","author":"L\u00f3pez-Mu\u00f1oz","year":"2004","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatr."},{"key":"10.1016\/j.brainresbull.2009.01.005_bib71","first-page":"242","article-title":"El papel hist\u00f3rico de los barbit\u00faricos en las \u201ccuras de sue\u00f1o\u201d de los trastornos psic\u00f3ticos y man\u00edacos","volume":"11","author":"L\u00f3pez-Mu\u00f1oz","year":"2004","journal-title":"Psiquiatr. Biol."},{"key":"10.1016\/j.brainresbull.2009.01.005_bib72","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1080\/10401230591002002","article-title":"History of the discovery and clinical introduction of chlorpromazine","volume":"17","author":"L\u00f3pez-Mu\u00f1oz","year":"2005","journal-title":"Ann. Clin. Psychiatry"},{"key":"10.1016\/j.brainresbull.2009.01.005_bib73","first-page":"387","article-title":"Aproximaci\u00f3n hist\u00f3rica al descubrimiento de la reserpina y su introducci\u00f3n en la cl\u00ednica psiqui\u00e1trica","volume":"32","author":"L\u00f3pez-Mu\u00f1oz","year":"2004","journal-title":"Actas Esp. Psiquiatr."},{"key":"10.1016\/j.brainresbull.2009.01.005_bib74","series-title":"Historia de la Psicofarmacolog\u00eda","first-page":"901","article-title":"Las terapias biol\u00f3gicas antes de la introducci\u00f3n de los modernos psicof\u00e1rmacos","author":"Mitchell","year":"2007"},{"key":"10.1016\/j.brainresbull.2009.01.005_bib75","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s00406-004-0497-y","article-title":"Obituary to Prof.h.c. Dr. Drs.h.c. mult. Paul Janssen","volume":"254","author":"M\u00fcller","year":"2004","journal-title":"Eur. Arch. Psychiatr. Clin. Neurosci."},{"key":"10.1016\/j.brainresbull.2009.01.005_bib76","series-title":"Paul Janssen and the Discovery of Haloperidol and Other Neuroleptics","author":"Niemegeers","year":"1988"},{"key":"10.1016\/j.brainresbull.2009.01.005_bib77","first-page":"45","article-title":"Bromperidol, a new potent neuroleptic of the butyrophenone series. Comparative pharmacology of bromoperidol and haloperidol","volume":"24","author":"Niemegeers","year":"1974","journal-title":"Arzneim. Forsch."},{"issue":"Suppl. 1","key":"10.1016\/j.brainresbull.2009.01.005_bib78","first-page":"3","article-title":"Pharmacology and biochemistry of haloperidol","volume":"69","author":"Niemegeers","year":"1976","journal-title":"Proc. R. Soc. Med."},{"key":"10.1016\/j.brainresbull.2009.01.005_bib79","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1097\/01.pra.0000281486.34817.8b","article-title":"The evolution of antipsychotic drug therapy: reserpine, chlorpromazine, and haloperidol","volume":"13","author":"Preskorn","year":"2007","journal-title":"J. Psychiatr. Pract."},{"key":"10.1016\/j.brainresbull.2009.01.005_bib80","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1176\/ajp.133.2.197","article-title":"The dopamine hypothesis of schizophrenia: focus on dopamine receptor","volume":"133","author":"Snyder","year":"1976","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.brainresbull.2009.01.005_bib81","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1213\/ane.0b013e3181605add","article-title":"A tribute to Paul A.J. Janssen: entrepreneur extraordinaire, innovative scientist, and significant contributor to anesthesiology","volume":"106","author":"Stanley","year":"2008","journal-title":"Anesth. Analg."},{"key":"10.1016\/j.brainresbull.2009.01.005_bib82","first-page":"492","article-title":"The significance of dopamine-receptor blockade for the mechanism of action of neuroleptic drugs","volume":"160","author":"Van Rossum","year":"1966","journal-title":"Arch. Int. Pharmacodyn. Ther."},{"key":"10.1016\/j.brainresbull.2009.01.005_bib83","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/j.neuint.2006.09.015","article-title":"Haloperidol induces neurotoxicity by the NMDA receptor downstream signaling pathway, alternative from glutamate excitotoxicity","volume":"50","author":"Zhuravliova","year":"2007","journal-title":"Neurochem. Int."}],"container-title":["Brain Research Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S036192300900032X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S036192300900032X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T20:04:45Z","timestamp":1759781085000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S036192300900032X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4]]},"references-count":83,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,4]]}},"alternative-id":["S036192300900032X"],"URL":"https:\/\/doi.org\/10.1016\/j.brainresbull.2009.01.005","relation":{},"ISSN":["0361-9230"],"issn-type":[{"value":"0361-9230","type":"print"}],"subject":[],"published":{"date-parts":[[2009,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The consolidation of neuroleptic therapy: Janssen, the discovery of haloperidol and its introduction into clinical practice","name":"articletitle","label":"Article Title"},{"value":"Brain Research Bulletin","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brainresbull.2009.01.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}